Moataz Karmalawy


Moataz Karmalawy is President and Chief Executive Officer of ProNova Solutions, LLC, and Senior Vice President of Provision Healthcare, LLC. Moataz is leading the strategic business development to revolutionize proton therapy in the market with ProNova’s state-of-the art proton therapy solutions and drive innovative partnerships to grow and develop comprehensive cancer care centers.

Moataz has established over 50 global comprehensive cancer centers with some of the world’s most prestigious institutes in North America, Asia and Europe as well as establishing manufacturing facilities and service organizations. He leverages over 25 years in creating significant value globally in healthcare and has cultivated and led high-performance teams during significant change events including acquisitions, post-merger integrations, joint ventures, and new product launches. The roles he has filled include a wide range of business sizes including President of businesses within Fortune 500 companies with full P&L responsibility, and Head of Operations and R&D as well as marketing roles within a Malcolm Baldrige award winning organization. He also founded, managed, sold, and integrated a startup company earlier in his career.

Moataz was previously President of Advanced Oncotherapy for several years. Prior to that, for 12 years, he served as the President of the Worldwide Particle Therapy business at Varian Medical Systems, the world’s market leader of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Prior to joining Varian, Moataz worked for ADAC/Philips Medical Systems for 10 years in a variety of roles including Vice President of Research and Development., Vice President of Operations and Vice President of Strategic Development. ADAC was the world market leader in Nuclear Medicine and is a Malcolm Baldrige National Quality Award-winning company. ADAC was acquired by Philips Healthcare, a leading health technology company in diagnostic imaging, image-guided therapy, patient monitoring, and health informatics, as well as in consumer health and home care.

Prior to Philips, Moataz spent 5 years at Park Medical Systems in Montreal, Canada directing their Nuclear Medicine Systems operations. He also founded and managed ACK Controls, a company specializing in the development of fully integrated hardware/software-based solutions for machinery monitoring, diagnosis, and prognosis. Moataz holds over 10 patents and has been published in major technical journals and conference proceedings worldwide.

Moataz holds an MBA, Technology Management, PhD, Master of Engineering, and Bachelor of Engineering from Concordia University, Montreal, Canada and Wharton School of Business, University of Pennsylvania, Octagon Executive Program.

Moataz is a member of several boards including: Founder and Chairman of the Board of Directors for The Alliance for Proton Therapy Access, the Executive Board Member of the SPTC Proton Therapy Center, and a Medical Scientific Board member of Ergea France (

David Liu


David leads Provision’s Asia market strategy and business development. David was a General Partner at Avoda Capital, a Shanghai based healthcare private equity firm and the founder and president of Cherokee Rose Group, a healthcare management consultancy advising clients on Sino-American market entry strategy and investment. David was Vice President and General Manager of McKesson-US Oncology Asia Pacific for nearly 10 years where he developed regional strategy, directed M&A activities, and negotiated partnerships with pharmaceutical and medical technology manufacturers. Prior to McKesson David was COO at, one of the largest global Asian e-commerce companies, backed by Walden Ventures and Morgan Stanley. David has also held senior positions in strategic planning, marketing, and operations at IBM, American Express, and Ernst & Young. He has lectured on start-up strategy and emerging markets private equity at Harvard Business School, The Wharton School and Peking University.

David has an MBA, a Masters’ Degree in Industrial Engineering, and a Bachelors’ of Science Degree in Operations Research from Cornell University.

Tracy Dobbs, MD


Dr. Dobbs is the Chief Medical Officer of Provision Healthcare, LLC and a Medical Oncologist and founder of the largest Medical Oncology group, Tennessee Cancer Specialists, in East Tennessee and the second largest in the state. He has been in practice for over 25 years and is director of 3 outlying medical oncology clinics which serve two states. Dr. Dobbs is a champion of research and is the Principal Investigator for many clinical trials and research grants. He has also co-authorized several publications.

Dr. Dobbs earned his medical degree from the University of Missouri in Kansas City. He completed his internal medicine internship and residency fellowship in hematology and oncology at the University of Oklahoma Health Sciences Center. Dr. Dobbs completed a post-graduate fellowship in medical oncology/hematology at the University of Oklahoma Health Sciences Center in Oklahoma City. He is board certified in internal medicine and medical oncology. Dr. Dobbs is a member of the American Society of Clinical Oncologists (ASCO), American Cancer Society, the Tennessee Medical Association, the Knoxville County Medical Associates, the American Society of Clinical Oncologists, the American Medical Association, and the American College of Physicians. He served as Chief of Staff of Baptist Hospital of East Tennessee from 1996-1997 and was Chairman of the Credentials Committee from 1994 to 1995. He was also a member of the Baptist Hospital of East Tennessee Board of Directors from 1993 to 2006. Currently he serves on the board of directors of the American Cancer Society, Department of Knox County Medical Associates, and Provision Healthcare.

Mary Lou DuBois


Mary Lou DuBois serves as the President of Provision Health Services, LLC, and holds the position of Senior Vice President at Provision Healthcare, LLC. She is a founder and board member of Provision Health Partners, LLC (PHP) and ProNova Solutions, LLC. Mary Lou spearheads the creation of cutting-edge cancer treatment centers, aimed at offering advanced diagnostic and therapeutic solutions for cancer patients.

During her tenure with Provision, Ms. DuBois played a pivotal role in overseeing the design, development, and launch of two proton therapy centers, steering them from inception to full operational capacity while surpassing set milestones. Additionally, she led the development of a third proton center, characterized by a streamlined footprint to reduce construction and development costs and improved patient workflow. Notably, Mary Lou initiated the “Culture of Care” program, a hallmark of Provision, which prioritizes individualized and compassionate patient experiences.

Ms. DuBois, during her presidency at PHP, orchestrated the strategic planning, construction, and management of two medical office complexes within Provision Health Alliance in Knoxville, Tennessee. These facilities encompassed a wide array of clinical outpatient services, including advanced diagnostic imaging, chemotherapy, radiation therapy, women’s health services, eye surgery, wellness programs, physical therapy, and research capabilities. Additionally, PHP provided comprehensive management services spanning Human Resources, IT, Marketing, Accounting, Billing, and Facilities Management.

Prior to her role at Provision Health Services, Ms. DuBois spent two decades at CTI Molecular Imaging, Inc. (CTI), where she held various positions of increasing responsibility. As an Officer and Vice President, Customer Solutions, she oversaw customer sales support and product management, coordinating the introduction and marketing of new technology products. Mary Lou also directed national sales meetings and represented CTI at industry-leading events such as the Radiological Society of North America and the Society of Nuclear Medicine.

Furthermore, Ms. DuBois led an IT development team at CTI, formulating an internet-based customer solutions strategy and managing the Customer Training Center for PET providers. In her role as Senior Director, Corporate Solutions, she provided leadership in implementing information technology initiatives for both internal and external stakeholders, including network infrastructure, telecommunications, and support services. Her tenure at CTI encompassed diverse roles in Human Resources, Facilities, and Administrative Services.

Mary Lou earned her Bachelor of Science degree in Business Management from Tennessee Wesleyan College.

Terry Douglass, Ph.D.


Terry Douglass is the Founder, Chairman of the Board of Directors, and Chief Executive Officer of Provision Healthcare, LLC. He is also the Chairman of Provision Trust, Inc., Provision Foundation, Inc., and Founder and Chairman of the Board of ProNova Solutions, LLC.

Dr. Douglass was Founder and served as the Chairman of the Board of CTI Molecular Imaging, Inc., a public company that specialized in the development, production and distribution of products and services for the medical diagnostic imaging market, from 1983 to 2005 when it was acquired by Siemens at a market capitalization of $1 billion. He also served as President and CEO of CTI Molecular Imaging from its formation in 1983 until 2003. During this tenure, Dr. Douglass played an integral role in the development and commercialization of positron emission tomography (PET) and its development globally, including PET cyclotron technology that now plays a significant role in proton therapy. He was also instrumental in the development of FDA approval for PET and Medicare reimbursement for PET services.

From 1968 to 1983, Dr. Douglass was employed at EG&G Ortec as a design engineer, marketing manager, and division manager and served as CEO and President during the last three years at EG&G Ortec.

Dr. Douglass is currently leading the development of the world-class comprehensive cancer care program for Provision Healthcare at Dowell Springs in Knoxville, Tenn. Dr. Douglass has served or is serving on other boards in addition to the Provision Boards and CTI Boards including the Whitestone Group, Computational Systems, Inc., EPRI, Ionogen, LLC, YMCA, Knoxville Chamber of Commerce, Hope Resource Center, Young Life, Vanderbilt Medical Advisory Board, and the UT Medical Center Biomedical Imaging Foundation.

Dr. Douglass graduated with Bachelor of Science, Masters’ of Science, and Ph.D. degrees in Electrical Engineering from the University of Tennessee.